研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

肾上腺皮质癌中18F-FDG摄取与肿瘤增殖抗原Ki-67表达呈正相关。

Positive Correlation Between 18F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.

发表日期:2023 Feb 07
作者: Rossella Libé, Aurore Pais, Florian Violon, Laurence Guignat, Fideline Bonnet, Olivier Huillard, Guillaume Assié, Martin Gaillard, Bertrand Dousset, Sébastien Gaujoux, Maxime Barat, Anthony Dohan, Mathilde Sibony, Jérôme Bertherat, Anne Segolene Cottereau, Florence Tenenbaum, Joël Coste, Lionel Groussin
来源: CLINICAL NUCLEAR MEDICINE

摘要:

肾上腺皮质癌(ACC)是一种极为罕见的内分泌恶性肿瘤,常规影像和激素检查无法诊断。18F-FDG PET可以帮助预测恶性程度,但需要更多数据以支持未来的指南。该研究共纳入63例经组织学证实的ACC患者(n=55)或具有类固醇过量分泌的肾上腺皮质癌转移患者(n=8)。所有患者都接受了18F-FDG PET检查,计算出SUVmax和肾上腺/肝SUVmax比值。将18F-FDG PET参数与临床、病理和预后数据进行比较。结果显示,56例患者(89%)的ACC具有肾上腺/肝SUVmax比值>1.45,这是预测恶性程度100%敏感性的先前定义的截止值。其中7例ACC(11%)没有良好的FDG摄取(肾上腺/肝SUVmax <1.45),其中大多数的增殖标记Ki-67表达水平<10%。发现18F-FDG PET参数(SUVmax和肾上腺/肝SUVmax比值)与肿瘤大小、ENSAT(欧洲肾上腺瘤研究网络)分期、总Weiss评分和Ki- 67之间有强相关性。SUVmax和Ki-67之间的明显相关性(r = 0.47,P = 0.0009)暗示着18F-FDG摄取水平与肿瘤增殖之间的关系。未发现18F-FDG PET参数与预后指标(无进展生存或总生存)之间的统计学显著性关联。这项大型队列研究显示,大多数的ACC表现出高的18F-FDG摄取。然而,观察到的SUVmax和Ki-67表达水平之间的正相关似乎解释了发现一些18F-FDG摄取较低或不存在的ACC的可能性。这些发现对于处理肾上腺占位患者具有实际意义。©2023 Wolters Kluwer Health,Inc.保留所有权利。
Adrenocortical carcinoma (ACC) is an extremely rare endocrine malignancy, which cannot always be diagnosed during conventional radiology and hormonal investigations. 18F-FDG PET could help predict malignancy, but more data are necessary to support future guidelines.A cohort of 63 patients with histologically proven ACC (n = 55) or metastatic ACC with steroid oversecretion (n = 8) was assembled. All patients underwent an 18F-FDG PET, and the SUVmax and the adrenal-to-liver SUVmax ratio were calculated. The 18F-FDG PET parameters were compared with clinical, pathological, and outcome data.Fifty-six of 63 patients (89%) had an ACC with an adrenal-to-liver SUVmax ratio >1.45, which was a previously defined cutoff value to predict malignancy with 100% sensitivity. Seven ACCs (11%) had a lower uptake (adrenal-to-liver SUVmax <1.45), most of them with a proliferation marker Ki-67 expression level <10%. A positive correlation between 18F-FDG PET parameters (SUVmax and adrenal-to-liver SUVmax ratio) and tumor size, ENSAT (European Network for the Study of Adrenal Tumors) staging, total Weiss score, and the Ki-67 was found. The strong correlation between SUVmax and Ki-67 (r = 0.47, P = 0.0009) suggests a relationship between 18F-FDG uptake levels and tumor proliferation. No statistically significant associations between outcome parameters (progression-free or overall survival) and 18F-FDG PET parameters were found.This large cohort study shows that most cases of ACC demonstrate high 18F-FDG uptake. However, the positive correlation observed between SUVmax and Ki-67 expression levels seems to explain the possibility of identifying some ACC with a low or inexistent 18F-FDG uptake. These findings have practical implications for the management of patients with an adrenal mass.Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.